Back
JPMorgan Chase & Co. Vs. Dianthus Therapeutics, Inc. Industry Stock Comparison
Buy
56
JPM
JPMorgan Chase & Co.
Last Price:
$308.11
Seasonality Move:
5.01%
Buy
75
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$45.52
Seasonality Move:
32.46%
Buy
56
JPMorgan Chase & Co. (JPM)
is a Buy
Is JPMorgan Chase & Co. a Buy, Sell or Hold?
-
The current JPMorgan Chase & Co. [JPM] share price is $310.90. The Score for JPM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
JPM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Dianthus Therapeutics, Inc. [DNTH] share price is $44.86. The Score for DNTH is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DNTH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JPM Stock Price Chart
What is JPMorgan Chase & Co.'s stock price today?
-
The JPMorgan Chase & Co. share price today is $310.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPM is experiencing selling pressure, which indicates risk of future bearish movement.
DNTH Stock Price Chart
What is Dianthus Therapeutics, Inc.'s stock price today?
-
The Dianthus Therapeutics, Inc. share price today is $44.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNTH is experiencing buying pressure, which is a positive indicator for future bullish movement.
JPM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.81 | Buy |
| Relative Strength Index (14 RSI): | 40.79 | Sell |
| Chaikin Money Flow: | -18590996 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (313.44 - 329.24) | Sell |
| Bollinger Bands (100): | (299.89 - 319.53) | Buy |
DNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 63.89 | Buy |
| Chaikin Money Flow: | 1054693 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.07 - 43.67) | Buy |
| Bollinger Bands (100): | (31.06 - 42.48) | Buy |
JPM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 326.94 | Sell |
| 20-day SMA: | 323.59 | Sell |
| 50-day SMA: | 315 | Sell |
| 200-day SMA: | 288.87 | Buy |
| 8-day EMA: | 323.78 | Sell |
| 20-day EMA: | 322.62 | Sell |
| 50-day EMA: | 316.55 | Sell |
| 200-day EMA: | 292.02 | Buy |
DNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.09 | Buy |
| 20-day SMA: | 40.88 | Buy |
| 50-day SMA: | 40.39 | Buy |
| 200-day SMA: | 28.05 | Buy |
| 8-day EMA: | 40.25 | Buy |
| 20-day EMA: | 40.58 | Buy |
| 50-day EMA: | 39.7 | Buy |
| 200-day EMA: | 31.69 | Buy |
JPMorgan Chase & Co. Earnings Growth & JPM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.11 per share, an increase this year of $1.68 per share, and an increase next year of $1.13 per share.
Dianthus Therapeutics, Inc. Earnings Growth & DNTH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.43 per share.
JPMorgan Chase & Co. Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dianthus Therapeutics, Inc. Technical Analysis
| Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||